Nexilico has received NIH funding to develop innovative microbiome-based solutions to address the harmful effects of xenobiotics—environmental toxins found in food, water, and other sources. Partnering with UC Berkeley and Microvi Biotech, the project will leverage the transformative power of the gut microbiome to detoxify these substances, with a focus on arsenic, one of the most dangerous environmental toxins affecting millions worldwide.
Read More
Microvi Biotech Inc. is thrilled to announce that it has been awarded the prestigious EPA Administrator's Award for Outstanding Accomplishments by a Small Business Contractor.
Read More
“We are excited to finalize this new technology for such a significant problem that affects the health of millions of people around globe,” said Dr. Fatemeh Shirazi, CEO of Microvi. “Our commitment to our customers in the drinking water industry has always been to offer the most reliable, advanced, safe, and cost-effective treatment technologies.”
Read More
This funding will specifically support Microvi in integrating specialized, high-throughput equipment to optimize material usage, reduce labor requirements, and promote liquid and chemical recycling—thereby contributing to Microvi’s accelerated global commercialization.
Read More
The in silico platform reduces the cost and timeframe of drug development by reducing the need for iterative pre-clinical experiments and better directing clinical trials, while increasing the effectiveness of the therapeutics themselves.
Read MoreThe project promises to improve fuel efficiency and economy. The project will create a bio-based fuel additive that can be blended with diesel fuel to significantly reduce soot and greenhouse gas emissions and yield cleaner engine operation in cold-weather conditions.
Read More
Microvi recently demonstrated the successful application of MNE for enhanced production of n-butanol. The trials have been funded by a USDA grant with results showing that MNE has a higher titer and yield compared to conventional fermentation processes.
Read MoreStudies completed over the past year, funded through a Phase II NIH grant, show unprecedented removal rates of 1,2,3-Trichloropropane (TCP) and co-contaminants using Microvi’s cometabolism treatment technology.
Read MoreThe technology called MB-COMET™, based on Microvi’s MicroNiche Engineering™ technology, is a versatile biocatalytic solution based on the nexus of advanced materials science and microbial ecology.
Read MoreARPA-E supports the development of transformational energy technologies with the potential for high impact on society.
Read MoreThe technology overcomes toxic and inhibitory effects on butanol producing microorganisms, a major bottleneck in scaling existing biobutanol processes.
Read More